Tarlatamab-Imdelltra price per vial and drug purchase channel reference

Tarlatamab (trade name: Imdelltra) is a new type of targeted immunotherapy drug, mainly used to treat specific types of solid tumors, especially patients with refractory tumors such as small cell lung cancer. The drug uses a bispecific antibody mechanism to activate T cells in the patient's body to recognize and attack tumor cells, thereby achieving tumor killing effect. The development and marketing of talatumumab provides new treatment options for some patients with advanced tumors, especially for patients who are resistant to traditional chemotherapy and targeted therapy.

In the domestic market, talatumumab has not yet been officially launched. Currently, the drug is submitting a marketing application, and it is believed that it will gradually enter the domestic market in the future, but it is not yet included in the scope of domestic medical insurance reimbursement at this stage. Therefore, if domestic patients need to use talatumumab, they need to obtain it through clinical trials or special import channels. The specific price and purchase method will need to be announced by the drug management department and hospital pharmacies after it is officially launched.

In overseas markets, talatumumab was approved by the US FDA for marketing in May 2024, with two specifications: 1 mg and 10 mg. The price of each vial of 1mg specification is approximately RMB 25,000, and the price of each vial of 10mg specification is approximately RMB 148,000. This price level reflects the research and development costs and clinical value of its new targeted immune drugs, and also imposes a high economic burden on patients and medical institutions.
Currently, there are no generic drugs of Talatumumab on the market, so overseas original drugs are the only source available. When patients obtain overseas drugs, they should purchase them through regular hospitals, certified pharmacies or legal import channels to ensure drug quality and safety. During use, it is necessary to strictly follow medical instructions, monitor immune responses and adverse reactions with regular follow-up visits, and adjust the dose reasonably according to the patient's weight, condition and tolerance to ensure the best therapeutic effect and safety.
Reference: https://www.drugs.com/